Research Catalog
Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. Breggin.
- Title
- Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. Breggin.
- Author
- Breggin, Peter Roger, 1936-
- Publication
- New York : Springer Pub. Co., [1997], ©1997.
Items in the Library & Off-site
Filter by
1 Item
| Status | Format | Access | Call Number | Item Location |
|---|---|---|---|---|
| Text | Request in advance | RC483 .B726 1997 | Off-site |
Holdings
Details
- Description
- xii, 306 pages : illustrations; 24 cm
- Subjects
- Psychotropic Drugs > adverse effects
- Mental Disorders > therapy
- United States
- Brain Damage, Chronic > etiology
- Brain damage > Etiology
- Electroconvulsive therapy > Complications
- Psychotropic drugs > Side effects
- Iatrogenic diseases
- Brain > Effect of drugs on
- Legislation
- Electroconvulsive Therapy > adverse effects
- Drug Industry
- Genre/Form
- Legislation.
- Bibliography (note)
- Includes bibliographical references and index.
- Contents
- 1. The Brain-Disabling Principles of Psychiatric Treatment -- 2. Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics -- 3. Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression -- 4. Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Tardive Dystonia, and Tardive Akathisia -- 5. Neuroleptic-Induced Brain Damage, Persistent Cognitive Deficits, Dementia, and Psychosis -- 6. Antidepressants, Including Prozac-Induced Violence and Suicide -- 7. Lithium and Other Drugs for Bipolar Disorder -- 8. Electroshock for Depression -- 9. Stimulants and Other Drugs for Children, Including an Analysis of Attention-Deficit Hyperactivity Disorder -- 10. Antianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion -- 11. Drug Companies and the Food and Drug Administration: Failed Mandates.
- ISBN
- 0826194907
- LCCN
- 97003969
- Owning Institutions
- Columbia University Libraries